Bili Zhang

900 total citations
45 papers, 486 citations indexed

About

Bili Zhang is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Bili Zhang has authored 45 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 10 papers in Nephrology. Recurrent topics in Bili Zhang's work include Renal Diseases and Glomerulopathies (7 papers), Cancer-related molecular mechanisms research (5 papers) and Pediatric Urology and Nephrology Studies (4 papers). Bili Zhang is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Cancer-related molecular mechanisms research (5 papers) and Pediatric Urology and Nephrology Studies (4 papers). Bili Zhang collaborates with scholars based in China, Canada and Australia. Bili Zhang's co-authors include Xianxian Zhao, Zhifu Guo, Hong Wu, Yuan Bai, Xianxian Zhao, Chaoqun Ma, Jiawei Gu, Pan Li, Liang Zhang and Yu Liu and has published in prestigious journals such as Circulation Research, Scientific Reports and The FASEB Journal.

In The Last Decade

Bili Zhang

40 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bili Zhang China 11 128 116 86 77 64 45 486
Zhenghui Xiao China 14 210 1.6× 67 0.6× 72 0.8× 153 2.0× 108 1.7× 86 690
Yuming Li China 11 138 1.1× 51 0.4× 43 0.5× 53 0.7× 75 1.2× 23 459
Jingbo Zhao China 12 190 1.5× 37 0.3× 72 0.8× 119 1.5× 56 0.9× 46 560
Jalal Etemadi Iran 12 96 0.8× 36 0.3× 45 0.5× 52 0.7× 88 1.4× 52 462
Eirik Ikdahl Norway 12 74 0.6× 104 0.9× 203 2.4× 57 0.7× 120 1.9× 42 781
Hongyang Xu China 11 96 0.8× 89 0.8× 24 0.3× 38 0.5× 126 2.0× 34 422
Mariam Arabi Lebanon 14 119 0.9× 86 0.7× 150 1.7× 120 1.6× 98 1.5× 85 586
Shu Qin China 12 75 0.6× 185 1.6× 287 3.3× 63 0.8× 77 1.2× 31 586
Ana Garcia Diaz United Kingdom 11 90 0.7× 49 0.4× 38 0.4× 95 1.2× 34 0.5× 21 474

Countries citing papers authored by Bili Zhang

Since Specialization
Citations

This map shows the geographic impact of Bili Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bili Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bili Zhang more than expected).

Fields of papers citing papers by Bili Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bili Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bili Zhang. The network helps show where Bili Zhang may publish in the future.

Co-authorship network of co-authors of Bili Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Bili Zhang. A scholar is included among the top collaborators of Bili Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bili Zhang. Bili Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Faguang, Bili Zhang, Zhifu Guo, et al.. (2025). Enhancer-Associated LncRNA-ITGA2 Promotes Vascular Remodeling Through ITGA2. Circulation Research. 136(12). 1610–1628. 2 indexed citations
2.
Zhang, Bili, et al.. (2024). Associations of triglyceride-glucose (TyG) index with chest pain incidence and mortality among the U.S. population. Cardiovascular Diabetology. 23(1). 111–111. 28 indexed citations
3.
Song, Xiaowei, Ting Su, Changjin Li, et al.. (2024). Abnormal expression of PRKAG2-AS1 in endothelial cells induced inflammation and apoptosis by reducing PRKAG2 expression. Non-coding RNA Research. 9(2). 536–546. 1 indexed citations
4.
Li, Pan, Liang Zhang, Bo Li, et al.. (2023). The first experience of multi-gripper robot assisted percutaneous coronary intervention in complex coronary lesions. Journal of Geriatric Cardiology. 20(8). 608–611. 2 indexed citations
5.
Song, Xiaowei, Ting Su, Changjin Li, et al.. (2023). Abnormal expression of PRKAG2-AS results in dysfunction of cardiomyocytes through regulating PRKAG2 transcription by interacting with PPARG. Clinical Epigenetics. 15(1). 178–178. 2 indexed citations
6.
Gao, Rui, Chunlin Li, Xiaoling Tong, et al.. (2020). Identification, expression, and artificial selection of silkworm epigenetic modification enzymes. BMC Genomics. 21(1). 740–740. 3 indexed citations
7.
8.
Zhang, Liang, Pan Li, Bili Zhang, et al.. (2020). Dysregulation of HULC promotes contrast-induced nephropathy (CIN) via regulating signaling pathway of miRNA-512 and prostaglandin E1 (PGE1). Scientific Reports. 10(1). 11691–11691. 3 indexed citations
9.
Zhang, Ying, et al.. (2019). Evaluation of Novel Biomarkers for Early Diagnosis of Acute Kidney Injury in Asphyxiated Full-Term Newborns: A Case-Control Study. Medical Principles and Practice. 29(3). 285–291. 20 indexed citations
10.
Liu, Yan, Bili Zhang, & Wenhong Wang. (2018). Risk factor and drug-resistance analysis of acute pyelonephritis in children. Zhonghua shiyong erke linchuang zazhi. 33(22). 1727–1730.
11.
Yu, Manli, et al.. (2015). Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Cardiovascular Pathology. 24(6). 375–381. 83 indexed citations
12.
Zhang, Meiyan, et al.. (2014). Functional Polymorphisms in Interleukin-23 Receptor and Susceptibility to Coronary Artery Disease. DNA and Cell Biology. 33(12). 891–897. 28 indexed citations
13.
Zhang, Bili, et al.. (2013). A prospective randomly controlled clinical trial on azithromycin therapy for induction treatment of children with nephrotic syndrome. European Journal of Pediatrics. 173(4). 509–515. 12 indexed citations
14.
15.
Zhang, Bili. (2012). Effect of Curcumin on protection of organ function and serum levels of IL-18 in LPS-induced sepsis in rats. The Journal of clinical Pediatrics. 1 indexed citations
16.
Zhang, Bili, et al.. (2012). [Spectrum and drug sensitivity of pathogenic bacteria in children with nephrotic syndrome complicated by urinary tract infection: an analysis of 97 cases].. PubMed. 14(9). 657–60. 4 indexed citations
17.
18.
Zhang, Bili, et al.. (2010). A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy.. PubMed. 16(4). CS41–44. 6 indexed citations
19.
Li, Zhaofeng, Shu-Wei Song, Yong-wen QIN, et al.. (2009). Bolus intravenous injection of obestatin does not change blood pressure level of spontaneously hypertensive rat. Peptides. 30(10). 1928–1930. 16 indexed citations
20.
Zhang, Bili, et al.. (2008). [Study on renoprotective effect of Xuebijing and Rosiglitazone in rats with focal segmental glomerular fibrosis].. PubMed. 20(5). 299–300. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenghui Xiao Breakdown of academic impact, for papers by Yuming Li Breakdown of academic impact, for papers by Jingbo Zhao Breakdown of academic impact, for papers by Jalal Etemadi Breakdown of academic impact, for papers by Eirik Ikdahl Breakdown of academic impact, for papers by Hongyang Xu Breakdown of academic impact, for papers by Mariam Arabi Breakdown of academic impact, for papers by Shu Qin Breakdown of academic impact, for papers by Ana Garcia Diaz
Rankless by CCL
2026